GlobeImmune
Tarmogens, a targeted molecular immunotherapy for the treatment of cancer and infectious diseases. Learn more
Launch date
Employees
Market cap
€1.8m
Enterprise valuation
(€6m) (Public information from Sep 2024)
Share price
$0.0002 GBIM
Louisville Kentucky (HQ)
Authorizing premium user...